Operating Lease, Liability, Current in USD of NKGen Biotech, Inc. from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
NKGen Biotech, Inc. quarterly Operating Lease, Liability, Current history and change rate from Q4 2022 to Q4 2024.
  • NKGen Biotech, Inc. Operating Lease, Liability, Current for the quarter ending 31 Dec 2024 was $154,000.000.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $154,000 +$154,000 31 Dec 2024 10-K 08 Oct 2025
Q3 2024 $154,000 +$58,000 +60.4% 30 Sep 2024 10-Q 04 Mar 2025
Q2 2024 $154,000 30 Jun 2024 10-Q 12 Sep 2024
Q1 2024 $154,000 31 Mar 2024 10-Q 20 May 2024
Q4 2023 $0 -$379,000 -100% 31 Dec 2023 10-K 08 Oct 2025
Q3 2023 $96,000 30 Sep 2023 10-Q 14 Nov 2023
Q4 2022 $379,000 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.